| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 北京键凯科技股份有限公司（证券代码688356，证券简称键凯科技）是2001年10月注册成立的致力于医用药用聚乙二醇衍生物产业化的高新技术企业，注册于北京市海淀区。 目前，公司已在天津开发区西区生物医药园建成占地15000多平方米的医用药用聚乙二醇衍生物的开发及产业化基地，在辽宁省盘锦市精细化工产业园建成了高纯度医用药用聚乙二醇材料的研发与全自动生产线。目前公司及子公司天津键凯科技有限公司、辽宁键凯科技有限公司均获得高新技术企业认证，是国内外为数不多能进行高纯度和低分散度的医用药用聚乙二醇及活性衍生物工业化生产的公司，是国内规模化生产高质量医用药用聚乙二醇及其衍生物领域的先行者之一，也是主要新兴参与者。 键凯科技支持我国境内6个已上市的聚乙二醇修饰药物的研发和生产，3个已上市的国际医疗器械产品及一款商业化的国际药物端产品。为数家国际医药企业提供其三类医疗器械生产所需的医用药用聚乙二醇及其活性衍生物。除此之外，公司还支持了多家国内国际药企及医疗器械企业的数十个II、III期临床项目，拥有800余家国际客户及300余家国内客户。 公司已于2020年8月26日正式登陆上海证券交易所科创板。 | ||||||||||||||||||||||||
| Main Business | 主要从事医用药用聚乙二醇及其活性衍生物的研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | 赵宣 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 陈斌 | ||||||||||||||||||||||||
| Solicitors | 北京安杰律师事务所 | ||||||||||||||||||||||||
| Auditors | 普华永道中天会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-82893760 | ||||||||||||||||||||||||
| Fax No | 010-82893023 | ||||||||||||||||||||||||
| Website | www.jenkem.com | ||||||||||||||||||||||||
| ir@jenkem.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 26/08/2020 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 1.920 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.574 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 21.119 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.564B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |